Trial intelligence / Profile preview

Colchicine for PPMI Prevention in Elective PCI

NCT03735134Unknown

Sponsor
Hillel Yaffe Medical Center
Start
Nov 2018
Primary completion
Jul 2020
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised trial of colchicine in myocardial infarction (MI), sponsored by Hillel Yaffe Medical Center. Primary endpoint: Periprocedural Myocardial Infarction at 24 hours. Status: unknown.

02

Drugs

colchicine
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT03735134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03735134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call